This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Tai X, Cowan M, Feigenbaum L, Singer A . CD28 costimulation of developing thymocytes induces Foxp3 expression and regulatory T cell differentiation independently of interleukin 2. Nat Immunol 2005; 6: 152–162.
Sakaguchi S . The origin of FOXP3-expressing CD4+ regulatory T cells: thymus or periphery. J Clin Invest 2003; 112: 1310–1312.
Bennett CL, Christie J, Ramsdell F, Brunkow ME, Ferguson PJ, Whitesell L et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 2001; 27: 20–21.
Smyk-Pearson SK, Bakke AC, Held DK, Wildin RS . Rescue of the autoimmune scurfy mouse by partial bone marrow transplantation, or by injection with T-enriched splenocytes. Clin Exp Immunol 2003; 133: 193–199.
Wildin RS, Smyk-Pearson S, Filipovich AH . Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome. J Med Genet 2002; 39: 537–545.
Powell BR, Buist NR, Stenzel P . An X-linked syndrome of diarrhea, polyendocrinopathy, and fatal infection in infancy. J Pediatr 1982; 100: 731–737.
Peake JEMR, Byrne G, Shepherd R . X-linked immune dysregulation, neonatal insulin dependent diabetes, and intractable diarrhea. Arch Dis Child 1996; 74: 195–199.
Clark LB, Appleby MW, Brunkow ME, Wilkinson JE, Zeigler SF, Ramsdell F et al. Cellular and molecular characterization of the scurfy mouse mutant. J Immunol 1999; 162: 2546–2554.
Bindl L, Torgerson T, Perroni L, Youssef N, Ochs HD, Goulet O et al. Successful use of the new immune-suppressor sirolimus in IPEX (immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome). J Pediatr 2005; 147: 256–259.
Baud O, Goulet O, Canioni D, Le Deist F, Radford I, Rieu D et al. Treatment of the immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) by allogeneic bone marrow transplantation. N Engl J Med 2001; 344: 1758–1762.
Mazzolari E, Forino C, Fontana M, D’Ippolito C, Lanfranchi A, Gambineri E et al. A new case of IPEX receiving bone marrow transplantation. Bone Marrow Transplant 2005; 35: 1033–1034.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lucas, K., Ungar, D., Comito, M. et al. Submyeloablative cord blood transplantation corrects clinical defects seen in IPEX syndrome. Bone Marrow Transplant 39, 55–56 (2007). https://doi.org/10.1038/sj.bmt.1705542
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1705542
This article is cited by
-
Autoimmune Enteropathy: An Updated Review with Special Focus on Stem Cell Transplant Therapy
Digestive Diseases and Sciences (2019)
-
Single centre experience of haematopoietic SCT for patients with immunodysregulation, polyendocrinopathy, enteropathy, X-linked syndrome
Bone Marrow Transplantation (2014)
-
ICON: The Early Diagnosis of Congenital Immunodeficiencies
Journal of Clinical Immunology (2014)
-
Immunodysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome: an unusual cause of proteinuria in infancy
Pediatric Nephrology (2007)